Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP Workshop
American Journal of Clinical Pathology · 2023
DOI: 10.1093/ajcp/aqad023 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2023. Verfasst von Reza Nejati und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Multiple Myeloma, Hodgkin Disease, Neoplasms, Plasma Cell, Lymphoma, B-Cell. Die Arbeit nennt 54 Literaturangaben.
Abstract (Originalsprache)
Objectives
To summarize cases submitted to the 2021 Society for Hematopathology/European Association for Haematopathology Workshop under the categories of progression of Hodgkin lymphoma, plasmablastic myeloma, and plasma cell myeloma.
Methods
The workshop panel reviewed 20 cases covered in this session. In addition, whole-exome sequencing (WES) and whole-genome RNA expression analysis were performed on 10 submitted cases, including 6 Hodgkin lymphoma and 4 plasma neoplasm cases.
Results
The cases of Hodgkin lymphoma included transformed cases to or from various types of B-cell lymphoma with 1 exception, which had T-cell differentiation. The cases of plasma cell neoplasms included cases with plasmablastic progression, progression to plasma cell leukemia, and secondary B-lymphoblastic leukemia. Gene variants identified by WES included some known to be recurrent in Hodgkin lymphoma and plasma cell neoplasm. All submitted Hodgkin lymphoma samples showed 1 or more of these mutations: SOCS1, FGFR2, KMT2D, RIT1, SPEN, STAT6, TET2, TNFAIP3, and ZNF217.
Conclusions
Better molecular characterization of both of these neoplasms and mechanisms of progression will help us to better understand mechanisms of progression and perhaps develop better prognostic models, as well as identifying novel therapeutic targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Fox Chase Cancer Center, Philadelphia, PA, USA.
- Department of Pathology, University of Miami Miller School of Medicine, Miami, FL, USA.
- Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA.
- Data Driven Bioscience (DDB), Durham, NC, USA.
- Department of Medcine, Duke University School of Medicine, Durham, NC, USA.
- Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
ORCID-Profile: Mariusz A Wasik, Wenbin Xiao, James R Cook
Zitieren
APA
Nejati, R., Amador, C., Czader, M., Thacker, E., Thakkar, D., Dave, S. S., Dogan, A., Duffield, A., Goodlad, J. R., Ott, G., Wasik, M. A., Xiao, W., & Cook, J. R. (2023). Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP Workshop. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqad023
Vancouver
Nejati R, Amador C, Czader M, Thacker E, Thakkar D, Dave SS, et al. Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP Workshop. American Journal of Clinical Pathology. 2023. doi:10.1093/ajcp/aqad023
BibTeX
@article{Nejati2023,
author = {Nejati, Reza and Amador, Catalina and Czader, Magdalena and Thacker, Elizabeth and Thakkar, Devang and Dave, Sandeep S and Dogan, Ahmet and Duffield, Amy and Goodlad, John R and Ott, German and Wasik, Mariusz A and Xiao, Wenbin and Cook, James R},
title = {Progression of Hodgkin lymphoma and plasma cell neoplasms: Report from the 2021 SH/EAHP Workshop},
journal = {American Journal of Clinical Pathology},
year = {2023},
doi = {10.1093/ajcp/aqad023}
}
EUVIMED